Bill Commons

TN SB 48

enacted

Opioids - As enacted, adds Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., Sun Pharmaceutical Industries, Inc., Indivior Inc., Viatris Inc., and Purdue Pharma L.P. to the list of companies that may be released by the attorney general and reporter for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.

Tennessee · 114S1 · upper

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did TN SB 48 pass?

Yes. TN SB 48 has been enacted into law. Latest recorded action (2025-05-13): Pub. Ch. 302

What is TN SB 48 about?

TN SB 48 is a bill in the 114S1 titled “Opioids - As enacted, adds Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., Sun Pharmaceutical Industries, Inc., Indivior Inc., Viatris Inc., and Purdue Pharma L.P. to the list of companies that may be released by the attorney general and reporter for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.”.

Who sponsors TN SB 48?

Haile is the primary sponsor of TN SB 48.

Introduced
2025-01-14
Latest action
2025-05-13 — Pub. Ch. 302
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Haileprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2025-05-13

    Pub. Ch. 302

  2. 2025-05-13

    Effective date(s) 05/02/2025

  3. 2025-05-02

    Signed by Governor.

    executive-signature

  4. 2025-04-22

    Transmitted to Governor for action.

    executive-receipt

  5. 2025-04-21

    Enrolled and ready for signatures

    enrolled

  6. 2025-04-21

    Signed by Senate Speaker

    passage

  7. 2025-04-21

    Signed by H. Speaker

    passage

  8. 2025-04-16

    Subst. for comp. HB.

    substitution

  9. 2025-04-16

    Am. withdrawn. (Amendment 1 - HA0377)

    amendment-withdrawal

  10. 2025-04-16

    Passed H., Ayes 91, Nays 0, PNV 1

    passage

  11. 2025-03-13

    Rcvd. from S., held on H. desk.

  12. 2025-03-10

    Senate adopted Amendment (Amendment 1 - SA0041)

  13. 2025-03-10

    Passed Senate as amended, Ayes 29, Nays 0, PNV 1

    passage

  14. 2025-03-10

    Engrossed; ready for transmission to House

    receipt

  15. 2025-03-07

    Placed on Senate Regular Calendar for 3/10/2025

  16. 2025-03-04

    Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays0 PNV 0

  17. 2025-02-26

    Placed on Senate Judiciary Committee calendar for 3/4/2025

  18. 2025-01-15

    Passed on Second Consideration, refer to Senate Judiciary Committee

    referral-committee

  19. 2025-01-14

    Introduced, Passed on First Consideration

    introduction

  20. 2025-01-09

    Filed for introduction

    filing

Versions

Documents

Votes

  • SENATE JUDICIARY COMMITTEE: Recommended for passage with amdt, refer to Senate Calendar Committee 3/4/2025 Passed

    2025-03-04 · pass · 9-0

  • FLOOR VOTE: as Amended Third Consideration 3/10/2025 Passed

    2025-03-10 · pass · 29-0

    Member-level votes (1)
    • Lamar: not voting
  • FLOOR VOTE: REGULAR CALENDAR PASSAGE ON THIRD CONSIDERATION 4/16/2025 Passed

    2025-04-16 · pass · 91-0

    Member-level votes (1)
    • Hulsey: not voting

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:32:51.339172Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=TN&identifier=SB 48. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.